A new clinical trial from Scripps Research in La Jolla aims to make significant gains in the global fight against malaria by ...

The winner plays for the championship Saturday at 4:30 p.m. at Mount Vernon Nazarene against either No. 4 Fairbanks or No. 5 ...

Salesforce is expected to report fourth-quarter results after the market closes Wednesday, with analysts largely bullish on the cloud-based software company's stock, anticipating AI-driven gains.

The pharma industry is delivering game-changing therapies with favorable regulatory support. Amid this backdrop, investors ...

The discussion ended with a bold call to action for businesses, healthcare providers, and policymakers: health equity must be a priority—not just ethically, but economically. As Burgess put it: “This ...

The Pirates jumped out to a 23-6 lead after the opening quarter and outscored their opponents 17-2 in the second quarter and 17-3 in the third to open up a commanding lead in the win. Warren Garrison ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

The EMA is set to perform accelerated reviews of Gilead Sciences’ applications for its twice-yearly injectable for HIV ...

Gilead (GILD) announced that the European Medicines Agency has validated for parallel accelerated review the company’s marketing authorization ...

We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...

CompanyOverview|NASDAQ:GILD] Gilead Sciences Inc. (NASDAQ: GILD) stock surged to a new 52-week high at $106.69 recently on ...